Open AccessGleevec Target Abl Important for Normal Immune Activation of T Cells
Publication year - 2004
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.3.8.1117
Subject(s) - imatinib mesylate , abl , cancer research , immune system , imatinib , cancer cell , myeloid leukemia , leukemia , cancer , immunology , medicine , biology , microbiology and biotechnology , tyrosine kinase , signal transduction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom